About
Based on years of research and trials at major medical institutions, Rebion is commercializing the breakthrough Neural Performance Scanning (NPS) to identify and help manage life-altering diseases that manifest from functional impairments in the brain. NPS portable point-of-care devices provide previously unavailable information for fast and impactful triage, making early disease detection, intervention and customized treatment more accessible.
Technologies
Gmail
Google Apps
GoDaddy Hosting
Google Play
YouTube
Google Tag Manager
Google Analytics
Typekit
Remote
Sisense
Domo
KNIME
AI
Keywords
medical devices
optics
vision screening
amblyopia
strabismus
medical equipment manufacturing
neurotechnology
fda-cleared vision scanner
visual tracking impairments
neuro-visual pathway evaluation
healthcare technology
early intervention in eye diseases
strabismus detection
fovea function analysis
biometric eye measurement
retinal nerve fiber analysis
early disease detection
brain-eye pathway assessment
neurodiagnostic tools
neural performance scanning
portable point-of-care devices
micro-strabismus detection device
fda cleared vision device
vision screening for pediatric populations
clinical trials in ophthalmology
neuro-ophthalmology tools
neurophysiological assessment
healthcare equipment & supplies
pediatric vision screening
ophthalmology
Company Information
-
Employees 14
-
Founded 2009
-
Total Funding $19516390
Location
100 Cambridge St, Boston, Massachusetts, United States, 02114
